The study, which is based on 2018 data, also found that U.S. drug spending increased by 76 percent between 2000 and 2017, with drug costs expected to jump even higher over the next decade.
It also found that U.S. prices for brand name drugs were an average of 3.44 times higher than other countries’ prices. However, U.S. prices for generic drugs were lower, averaging only 84 percent of other countries’ prices.
Total drug sales for all 33 countries examined in the study came to $795.2 billion. The U.S. accounted for 58 percent of these sales, even though drug sales from the country made up just 24 percent of the volume.
Prescription drug spending accounts for more than 10 percent of all U.S. healthcare spending, according to the study.
More articles on pharmacy:
Walgreens taps Starbucks exec as new CEO
Sanofi to manufacture 125M doses of Pfizer’s COVID-19 vaccine
Most pregnant women shouldn’t get COVID-19 vaccines, WHO says
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
